Resources Contact Us Home
A.sub.3 adenosine receptor agonists

Image Number 14 for United States Patent #5688774.

The present invention provides A.sub.3 selective agonists, particularly, adenine compounds having selected substituents at the 2, 6, and 9 positions, and related substituted compounds, particularly those containing substituents on the benzyl and/or uronamide groups, as well as pharmaceutical compositions containing such compounds. The present invention also provides a method of selectively activating an A.sub.3 adenosine receptor in a mammal, which method comprises acutely or chronically administering to a mammal in need of selective activation of its A.sub.3 adenosine receptor a therapeutically or prophylactically effective amount of a compound which binds with the A.sub.3 receptor so as to stimulate an A.sub.3 receptor-dependent response.

  Recently Added Patents
Bad column management with bit information in non-volatile memory systems
Analog to digital converter with increased sub-range resolution
Methods and systems for enabling community-tested security features for legacy applications
Profile and template based dynamic portable user workflow
Subpixel-based image down-sampling
Process for the production of alcohol
Method to alter silicide properties using GCIB treatment
  Randomly Featured Patents
Smoke or fire detector
Image testing method
Transferring spittoon system for waste inkjet ink
Recording tape cartridge
Fluid motor drives pump having an active inlet valve
Dynamic protection integrated device, in particular for MOS input stages integrated circuits
Pharmaceutical composition for treating or preventing allergic rhinitis
Separation process using pervaporation and dephlegmation
Precious stone